Source: PR Newswire

Press Release: Array BioPharma : Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2019

BOULDER, Colo., May 7, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today reported results for its third quarter of fiscal 2019 and provided an update on the progress of its key commercial products and clinical development programs. "U.S. demand for BRAFTOVI + MEKTOVI for...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more